10x GenomicsHQ United States · North America
Genomics & precision medicine
FY2025 revenue $642.8m (+5.2%); operating margin -9.5%; net loss $43.5m.
Revenue includes $44.1m patent settlement; underlying revenue fell 2%. No debt.
Financial health: WeakRisk summary →
No reviews yet
View profile